Nash fibrosure blood test. The Enhanced Liver Fibrosis (ELF™) blood test is a simple, accurate, noninvasive test that provides a simple, unitless numeric score that is generated via an algorithm for use in advanced liver fibrosis. 0) of liver fibrosis (Metavir F0-F4), hepatic steatosis (0. This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction-associated steatotic liver disease (MASLD). NASH-FibroTest is a complete diagnostic test for the liver It is pain-free, simple to use, and affordable, while offering high standards of performance. Quantitative results of 10 biochemicals in combination with age and gender are analyzed using a computational algorithm to provide a quantitative surrogate marker (0. 0, S0-S3), and nonalcoholic steatohepatitis (NASH . This test uses a combination of biomarkers to evaluate the extent of liver damage. May include intervals based on age and sex when appropriate. Interpretation of the scores is provided in the report. The absence of steatosis (S<0. Nonalcoholic Steatohepatitis (NASH)-FibroTest, Serum and Plasma Test ID:99981231160000-08'00' NSFIB Useful for: Diagnosis and the follow-up of liver fibrosis, steatosis and inflammation Estimating hepatic fibrosis This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Test Information This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). One of the most reliable ways to assess liver fibrosis in patients with NASH is through diagnostic tests like the Fibrosure NASH test. The NASH FibroSure test is a validated non-invasive assessment that combines multiple biomarkers to help evaluate fibrosis and inflammation associated with fatty liver disease. The NASH FibroSure Non-Alcoholic Fatty Liver Disease (NAFLD) Blood Test is a non-invasive blood test used to evaluate key markers associated with fatty liver disease. One comprehensive test, three unique scores NASH FibroSure® Plus is the leading noninvasive blood-based diagnostic for MASH, and is the only test to assess and produce a score for each feature of MASH—fibrosis, steatosis and steatohepatitis. This test provides numeric scores that assess hepatic fibrosis (FibroTest), hepatic inflammation (NashTest 2), and steatosis (SteatoTest 2). This test estimates the 3 elementary features of metabolic liver disease: steatosis, activity, and fibrosis. NASH-FibroTest™ offers an end-to-end liver diagnostic service from a single blood sample. 41) precludes the diagnosis of NASH, now known as metabolic dysfunction-associated steatohepatitis (MASH). 0-1. Oct 28, 2025 ยท This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Results from these tests are combined with the patient's age and sex to estimate hepatic fibrosis (FibroTest), steatosis (SteatoTest 2), and activity (NashTest 2) scores. Describes reference intervals and additional information for interpretation of test results. sfhqrqetnnqaetglogtnnlkogsw